Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInvestment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pharming Group N.V (PHAR) Revenue: 2018-2024

Historic Revenue for Pharming Group N.V (PHAR) over the last 7 years, with Dec 2024 value amounting to $297.2 million.

  • Pharming Group N.V's Revenue rose 29.98% to $97.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $263.8 million, marking a year-over-year decrease of 7.67%. This contributed to the annual value of $297.2 million for FY2024, which is 21.15% up from last year.
  • As of FY2024, Pharming Group N.V's Revenue stood at $297.2 million, which was up 21.15% from $245.3 million recorded in FY2023.
  • In the past 5 years, Pharming Group N.V's Revenue registered a high of $297.2 million during FY2024, and its lowest value of $198.9 million during FY2021.
  • For the 3-year period, Pharming Group N.V's Revenue averaged around $249.4 million, with its median value being $245.3 million (2023).
  • Per our database at Business Quant, Pharming Group N.V's Revenue decreased by 6.27% in 2021 and then increased by 21.15% in 2024.
  • Over the past 5 years, Pharming Group N.V's Revenue (Yearly) stood at $212.2 million in 2020, then declined by 6.27% to $198.9 million in 2021, then rose by 3.39% to $205.6 million in 2022, then climbed by 19.30% to $245.3 million in 2023, then rose by 21.15% to $297.2 million in 2024.